Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1494, 2005-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The battle between brand-name and generic drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 501, 2006-01 ,pp. :
Pioglitazone pays dividends in type 2 diabetes mellitus
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Intensive management of early RA pays dividends
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Pioglitazone pays dividends in type 2 diabetes mellitus
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :